Search

Your search keyword '"AstraZeneca PLC -- Forecasts and trends"' showing total 1,553 results
Start Over Descriptor "AstraZeneca PLC -- Forecasts and trends"
1,553 results on '"AstraZeneca PLC -- Forecasts and trends"'

1. Q2 2025 Daiichi Sankyo Co Ltd Earnings Presentation - Final

Subjects
Merck & Company Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Chief operating officers -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Enhertu (Medication)
Abstract

Presentation HIROYUKI OKUZAWA, PRESIDENT, EXECUTIVE PRESIDENT, CHIEF OPERATING OFFICER, REPRESENTATIVE DIRECTOR, DAIICHI SANKYO CO LTD: I am Hiroyuki Okuzawa. Thank you for taking time out of your busy schedule to [...]

Published
2024

2. Half Year 2024 Angle PLC Earnings Call - Final

Subjects
AstraZeneca PLC -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business
Abstract

Presentation ANDREW NEWLAND, CHIEF EXECUTIVE, EXECUTIVE DIRECTOR, ANGLE PLC: Good morning, everybody, and welcome to ANGLE's interim presentation for 2024. Welcome to the analysts in Berenberg's offices here in London [...]

Published
2024

3. Half Year 2024 Innate Pharma SA Earnings Call - Final

Subjects
AstraZeneca PLC -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business
Abstract

Presentation OPERATOR: Thank you for standing by, and welcome to the Innate Pharma first-half 2024 financial results and business update. (Operator Instructions) Thank you. I'd now like to turn the [...]

Published
2024

4. GLP-1 Agonists Market to Grow Rapidly by 2034, Predicts DelveInsight

Subjects
AstraZeneca PLC -- Forecasts and trends, Novo Nordisk A/S -- Forecasts and trends, Medical research -- Forecasts and trends -- Reports, Medicine, Experimental -- Forecasts and trends -- Reports, Drugs -- Vehicles, Diabetes therapy -- Market size -- Reports -- Forecasts and trends, Patient compliance -- Forecasts and trends -- Reports, Hypoglycemic agents -- Reports -- Forecasts and trends, Type 2 diabetes -- Forecasts and trends -- Reports, Drug delivery systems -- Reports -- Forecasts and trends -- Market size, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Arts and entertainment industries
Abstract

GLP-1 Agonists Market to Grow Rapidly by 2034, Predicts DelveInsight | Key Companies - Novo Nordisk A/S, Veru Inc., Viking Therapeutics, Inc., Terns Pharmaceuticals, Inc., Eccogene, AstraZeneca The GLP-1 agonists [...]

Published
2024

5. AstraZeneca price target raised by 400 GBp at Jefferies, here's why

Subjects
AstraZeneca PLC -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

Jefferies raised the firm's price target on AstraZeneca to 11,700 GBp from 11,300 GBp and keeps a Hold rating on the shares. The firm's Q2 revenue forecast is 2% below [...]

Published
2024

6. This FTSE 100 hidden gem looks poised for further gains despite its 138pc surge. ROBERT STEPHENS QUESTOR STOCK PICKS Relx's strong competitive position in the data analysis sphere suggests there is more to come

Subjects
Unilever N.V. -- Forecasts and trends, RELX Group PLC -- Forecasts and trends, Hongkong and Shanghai Banking Corporation Ltd. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Investment analysis -- Forecasts and trends, Food industry -- Forecasts and trends, Banking industry -- Forecasts and trends, Stocks -- Forecasts and trends -- Prices and rates, Publishing industry -- Forecasts and trends, Economic forecasting -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Publishing industry, Market trend/market analysis, Food and beverage production/distribution software, Banking industry, General interest
Abstract

Byline: ROBERT STEPHENS QUESTOR STOCK PICKS Read Questor's rules of investment before you follow our tips: telegraph.co.uk/go/questorrules Relx is probably the biggest UK-listed company you have never heard of. Its [...]

Published
2024

7. Global Chronic Kidney Disease Burden Is Growing

Author

Persaud, Natasha

Subjects
AstraZeneca PLC -- Forecasts and trends, Chronic kidney failure -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Health
Abstract

Chronic kidney disease (CKD) is expected to affect 11.7% to 16.5% of the general population across 8 countries by 2032, and the global prevalence of advanced-stage disease may rise up [...]

Published
2024

8. New modelling reveals the escalating toll of chronic kidney disease on patients, planet and economies

Subjects
AstraZeneca PLC -- Forecasts and trends, Chronic kidney failure -- Economic aspects -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Pharmaceuticals and cosmetics industries
Abstract

A new modelling analysis by AstraZeneca, IMPACT CKD, forecasts up to 16.5% of the population across eight countries will suffer from chronic kidney disease (CKD) by 2032, including a rise [...]

Published
2024

9. Antiplatelet Market Analysis Report 2024, Featuring Profiles of AstraZeneca, Sanofi, Daiichi Sankyo, Bayer, Torrent Pharmaceuticals, Lupin, Cipla, Baxter, Takeda and Glenmark Pharmaceuticals - ResearchAndMarkets.com

Subjects
Bayer AG -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Medicine, Preventive -- Forecasts and trends -- Reports, Distribution channels -- Forecasts and trends -- Reports, Patient compliance -- Forecasts and trends -- Reports, Preventive health services -- Forecasts and trends -- Reports, Clopidogrel -- Forecasts and trends -- Reports, Cardiovascular diseases -- Reports -- Forecasts and trends, Direct market channel, Retail/reseller channel, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Antiplatelet Market: Analysis By Drug Class, By Route of Administration, By Distribution Channel, By Region Size and Trends' report has been added to ResearchAndMarkets.com's offering. The global [...]

Published
2024

10. Drug Discovery Market Is Expected To Reach RevenueOf USD 138.5 Bn By 2033, At 9.6% CAGR

Subjects
AstraZeneca PLC -- Forecasts and trends, Drug discovery -- Forecasts and trends, Drugs -- Forecasts and trends, Marketing research -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

New York: Dimension Market Research has issued the following news release: The Global Drug Discovery Market is projected to reach USD 60.9 billion in 2024 which is further anticipated to [...]

Published
2024

11. Bronchiectasis Market Size in the 7MM was ~USD 1,581.2 million in 2023, estimated DelveInsight

Subjects
Boehringer Ingelheim GmbH -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Business -- Research, Bronchiectasis -- Forecasts and trends, Epidemiology -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international, Fasenra (Medication)
Abstract

M2 PRESSWIRE-November 22, 2024-: Bronchiectasis Market Size in the 7MM was ~USD 1,581.2 million in 2023, estimated DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:21112024 DelveInsight's 'Bronchiectasis Market Insights, Epidemiology, and Market Forecast [...]

Published
2024

12. Multiple Myeloma Market on Track for Major Expansion by 2034, According to DelveInsight | Janssen Pharma, Regeneron Pharma, Johnson & Johnson Innovative Medicine, Bristol Myers Squibb, Regeneron

Subjects
Johnson & Johnson -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Regeneron Pharmaceuticals Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Celgene Corp. -- Forecasts and trends, Antineoplastic agents -- Forecasts and trends, Multiple myeloma -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Antimitotic agents -- Forecasts and trends, Market trend/market analysis, Business, Business, international, Carvykti (Medication)
Abstract

M2 PRESSWIRE-November 20, 2024-: Multiple Myeloma Market on Track for Major Expansion by 2034, According to DelveInsight | Janssen Pharma, Regeneron Pharma, Johnson & Johnson Innovative Medicine, Bristol Myers Squibb, [...]

Published
2024

13. Myocardial Infarction Market Expected to Experience Major Growth by 2034, According to DelveInsight | Pfizer, Novartis, AstraZeneca, Recardio, Idorsia Pharma, Eli Lilly and Company, Boehringer

Subjects
Bayer AG -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Boehringer Ingelheim GmbH -- Forecasts and trends, Novartis AG -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Heart attack -- Reports -- Forecasts and trends, Bivalirudin -- Reports -- Forecasts and trends, BCG vaccines -- Growth -- Forecasts and trends -- Reports, Dapagliflozin -- Forecasts and trends -- Reports, BCG -- Growth -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-November 20, 2024-: Myocardial Infarction Market Expected to Experience Major Growth by 2034, According to DelveInsight | Pfizer, Novartis, AstraZeneca, Recardio, Idorsia Pharma, Eli Lilly and Company, Boehringer (C)1994-2024 [...]

Published
2024

14. United States Leads Global Pancreatic Cancer Market with 50% Share, Surpassing EU4, UK, and Japan, Reports DelveInsight | AstraZeneca, Merck Sharp & Dohme LLC, Bayer, Roche, Celgene, BMS

Subjects
Bayer AG -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Celgene Corp. -- Forecasts and trends, Business -- Research, Adalimumab -- Forecasts and trends, Epidemiology -- Forecasts and trends, Pancreatic cancer -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international, Lynparza (Medication)
Abstract

M2 PRESSWIRE-November 20, 2024-: United States Leads Global Pancreatic Cancer Market with 50% Share, Surpassing EU4, UK, and Japan, Reports DelveInsight | AstraZeneca, Merck Sharp & Dohme LLC, Bayer, Roche, [...]

Published
2024

15. Chronic Obstructive Pulmonary Disease Market Size was valued at USD 16,075 million in 2023, estimated DelveInsight

Subjects
Regeneron Pharmaceuticals Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Business -- Research, Diseases -- United States -- France -- United Kingdom, Lung diseases, Obstructive -- Forecasts and trends -- Reports -- Statistics, Aclidinium bromide -- Forecasts and trends -- Reports -- Statistics, Epidemiology -- Forecasts and trends -- Reports -- Statistics, Pharmaceutical industry -- Statistics -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-November 13, 2024-: Chronic Obstructive Pulmonary Disease Market Size was valued at USD 16,075 million in 2023, estimated DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:13112024 DelveInsight's 'Chronic Obstructive Pulmonary Disease Market [...]

Published
2024

16. Sanofi/Regeneron Pharmaceuticals' DUPIXENT Approval Marks a Significant Shift in Chronic Obstructive Pulmonary Disease Treatment Landscape | DelveInsight

Subjects
Market trend/market analysis, Dupixent (Medication), Business -- Research, Respiratory agents -- Forecasts and trends, Atopic dermatitis -- Care and treatment, Lung diseases, Obstructive -- Care and treatment, Drug approval -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Regeneron Pharmaceuticals Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends
Abstract

After over a decade without notable progress in treating chronic obstructive pulmonary disease, patients with this ongoing condition now have two new treatment options, with more expected in the future. [...]

Published
2024

17. FTSE 100 drops to three-month low amid global sell-off

Subjects
United Kingdom. Bank of England -- Tax policy, Honeywell International Inc. -- Forecasts and trends, Boeing Co. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Vodafone Group PLC -- Forecasts and trends, Cellular telephone services industry -- Forecasts and trends, Aircraft industry -- Forecasts and trends, Stock markets -- Forecasts and trends, Stock price indexes -- Forecasts and trends, Military electronics industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Stock market, Wireless telecommunications service, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Byline: Chris Price, Business Live Blogger and Tim Wallace, Deputy Economics Editor and Alex Singleton, Business Reporter London's main stock index slid to its lowest closing price for three months [...]

Published
2024

18. Pulmonary Arterial Hypertension Drugs Market to Grow by USD 2.26 Billion from 2024-2028, as Rising PAH Prevalence Drives Demand with AI Redefining Market Landscape - Technavio

Subjects
Bayer AG -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Pulmonary hypertension -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Iloprost -- Forecasts and trends -- Market size, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: Report with market evolution powered by AI - The global pulmonary arterial hypertension (PAH) drugs market size is estimated to grow [...]

Published
2024

19. ROS1 Inhibitors Market Booms as Demand for Targeted Cancer Therapies Escalates | DelveInsight

Subjects
United States. Food and Drug Administration, AstraZeneca PLC -- Forecasts and trends, Tyrosine -- Supply and demand, Business -- Research, Lung cancer, Non-small cell -- Forecasts and trends -- Health aspects, Cancer -- Forecasts and trends -- Health aspects, Crizotinib -- Health aspects -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary, Xalkori (Medication) -- Supply and demand -- Health aspects
Abstract

The ROS-1 NSCLC current market is mainly dominated by tyrosine kinase inhibitors such as XALKORI at present and is anticipated to be dominated by Repotrectinib, Taletrectinib, and NVL-520 by 2034. [...]

Published
2024

20. Non-Alcoholic Steatohepatitis Market to Show Remarkable Growth Trends from 2023 to 2032, DelveInsight Reports | Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Viking Therapeutics, Madrigal

Subjects
Boehringer Ingelheim GmbH -- Forecasts and trends, Regeneron Pharmaceuticals Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Novo Nordisk A/S -- Forecasts and trends, BCG vaccines -- Growth -- Forecasts and trends -- Reports, BCG -- Growth -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-November 5, 2024-: Non-Alcoholic Steatohepatitis Market to Show Remarkable Growth Trends from 2023 to 2032, DelveInsight Reports | Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Viking Therapeutics, Madrigal (C)1994-2024 [...]

Published
2024

21. Rare Hematology Market to Grow by USD 4.58 Billion (2024-2028) as Strategic Portfolio Enhancements Drive Revenue; AI's Impact on Market Trends Report - Technavio

Subjects
United States. Food and Drug Administration -- Reports, Biogen Inc. -- Forecasts and trends, Takeda Pharmaceutical Company Ltd. -- Forecasts and trends, bluebird bio, Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, CSL Ltd. (Parkville, Victoria, Australia) -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Biological products industry -- Forecasts and trends -- Market size, Biotechnology industry -- Forecasts and trends -- Market size, Drug approval -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends -- Market size, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following press release: Report on how AI is redefining market landscape - The global rare hematology market size is estimated to grow by USD [...]

Published
2024

22. Rare Hematology Market to Grow by USD 4.58 Billion (2024-2028) as Strategic Portfolio Enhancements Drive Revenue; AI's Impact on Market Trends Report - Technavio

Subjects
Biogen Inc. -- Forecasts and trends, bluebird bio, Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, CSL Ltd. (Parkville, Victoria, Australia) -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Biological products industry -- Forecasts and trends -- Market size, Biotechnology industry -- Forecasts and trends -- Market size, Drug approval -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends -- Market size, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global rare hematology market size is estimated to grow by USD 4.58 billion [...]

Published
2024

23. ANCA-associated Vasculitis Market Expected to Experience Major Growth by 2034, According to DelveInsight | Chemocentryx, Amgen, GlaxoSmithKline, AstraZeneca, Staidson (Beijing) Biopharma, Novartis

Subjects
Novartis AG -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Biological products industry -- Forecasts and trends, Vasculitis -- Reports -- Forecasts and trends, BCG vaccines -- Growth -- Forecasts and trends -- Reports, BCG -- Growth -- Forecasts and trends -- Reports, Biological products -- Reports -- Growth -- Forecasts and trends, Epidemiology -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international, University of Edinburgh -- Reports -- Growth, Fasenra (Medication) -- Reports, Tavneos (Medication) -- Reports
Abstract

M2 PRESSWIRE-October 28, 2024-: ANCA-associated Vasculitis Market Expected to Experience Major Growth by 2034, According to DelveInsight | Chemocentryx, Amgen, GlaxoSmithKline, AstraZeneca, Staidson (Beijing) Biopharma, Novartis (C)1994-2024 M2 COMMUNICATIONS RDATE:28102024 [...]

Published
2024

24. Abdominal Aortic Aneurysm Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Lombard Medical, Merck Serono, AstraZeneca, Medtronic, RSPR Pharma AB, Nectero Medical LLC

Subjects
AstraZeneca PLC -- Forecasts and trends, BCG vaccines -- Growth -- Forecasts and trends -- Reports, BCG -- Growth -- Forecasts and trends -- Reports, Ticagrelor -- Forecasts and trends -- Reports, Abdominal aneurysm -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-October 28, 2024-: Abdominal Aortic Aneurysm Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Lombard Medical, Merck Serono, AstraZeneca, Medtronic, RSPR Pharma AB, Nectero Medical LLC [...]

Published
2024

25. Metastatic HER2-positive Breast Cancer Market Expected to Experience Major Growth by 2034, According to DelveInsight | Ambrx, Zymeworks/Jazz Pharma, Roche, Criterium, Seagen, Sichuan Baili Pharma

Subjects
Seagen Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, BCG vaccines -- Growth -- Forecasts and trends -- Reports, Metastasis -- Reports -- Forecasts and trends, BCG -- Growth -- Forecasts and trends -- Reports, Biotechnology industry -- Forecasts and trends, Epidemiology -- Forecasts and trends -- Reports, Breast cancer -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international, Enhertu (Medication) -- Reports, Tukysa (Medication) -- Reports
Abstract

M2 PRESSWIRE-October 25, 2024-: Metastatic HER2-positive Breast Cancer Market Expected to Experience Major Growth by 2034, According to DelveInsight | Ambrx, Zymeworks/Jazz Pharma, Roche, Criterium, Seagen, Sichuan Baili Pharma, (C)1994-2024 [...]

Published
2024

26. Obsessive Compulsive Disorder Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Biohaven Pharmaceuticals, Inc., AbbVie, Biohaven Pharmaceuticals, Inc., AstraZeneca

Subjects
Janssen Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, BCG vaccines -- Growth -- Forecasts and trends -- Reports, BCG -- Growth -- Forecasts and trends -- Reports, Obsessive-compulsive disorder -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-October 25, 2024-: Obsessive Compulsive Disorder Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Biohaven Pharmaceuticals, Inc., AbbVie, Biohaven Pharmaceuticals, Inc., AstraZeneca (C)1994-2024 M2 [...]

Published
2024

27. JAK Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 50+ Companies Working in the Domain

Subjects
Incyte Corp. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Forecasts and trends, Market trend/market analysis, Clinical trials -- Forecasts and trends, Business research -- Forecasts and trends, Baricitinib -- Forecasts and trends, Biotechnology industries -- Forecasts and trends, Medical research -- Forecasts and trends, Tofacitinib -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Medicine, Experimental -- Forecasts and trends, Business -- Research, Biotechnology industry -- Forecasts and trends
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following press release: DelveInsight's 'JAK Inhibitors Pipeline Insight 2024' report provides comprehensive global coverage of pipeline JAK inhibitors in various stages [...]

Published
2024

28. Oncology Market in India to Grow by USD 1.49 Billion from 2024-2028, Driven by Rising Cancer Prevalence, AI-Powered Market Evolution - Technavio

Subjects
3M Co. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends, Market size, Reports, Forecasts and trends, Research and development, Market trend/market analysis, Cancer treatment -- Reports -- Forecasts and trends, Paper products industry -- Forecasts and trends -- Market size, Cancer -- Forecasts and trends -- Reports, Cancer research -- Forecasts and trends -- Reports, Industrial research -- United Kingdom -- United States -- India, Pharmaceutical industry -- Forecasts and trends -- Market size, Oncology, Experimental -- Forecasts and trends -- Reports, Cancer -- Care and treatment -- Forecasts and trends -- Reports -- Research
Abstract

NEW YORK: Technavio has issued the following press release: Report on how AI is driving market transformation - The Oncology Market in India size is estimated to grow by USD [...]

Published
2024

29. Global Antibody-Drug Conjugate Market Set for a ~USD 26 Billion Surge by 2030 | DelveInsight

Subjects
ImmunoGen Inc. -- Forecasts and trends, Daiichi Sankyo Company Ltd. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Business -- Research, Biopharmaceutics -- Reports -- Forecasts and trends, Viral antibodies -- Reports -- Forecasts and trends, Antibodies -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following press release: DelveInsight's Antibody-drug Conjugate Market Insights report provides the current and forecast market analysis, individual leading antibody-drug conjugate companies' [...]

Published
2024

30. Diabetic Nephropathy Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | AstraZeneca, NeuroBo Pharma, Don-A ST, MThera Pharma , Grünenthal, Averitas Pharma, Daiichi Sankyo, Vertex

Subjects
Lexicon Pharmaceuticals Inc. -- Forecasts and trends, Vertex Pharmaceuticals Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, BCG vaccines -- Growth -- Forecasts and trends, BCG -- Growth -- Forecasts and trends, Diabetic nephropathies -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-October 22, 2024-: Diabetic Nephropathy Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | AstraZeneca, NeuroBo Pharma, Don-A ST, MThera Pharma , Grünenthal, Averitas Pharma, Daiichi [...]

Published
2024

31. 200+ Pharma Companies Vie for the Top Spot in the Expanding Antibody-Drug Conjugate Oncology Market | DelveInsight

Subjects
Jiangsu Hengrui Medicine Company Ltd. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Eisai Company Ltd. -- Forecasts and trends, Business -- Research, Biopharmaceutics -- Reports -- Forecasts and trends, Viral antibodies -- Reports -- Forecasts and trends, Antibodies -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Trodelvy (Medication) -- Reports
Abstract

LAS VEGAS: DelveInsight Business Research, LLP has issued the following press release: DelveInsight's 'Antibody-drug Conjugates in Oncology Competitive Landscape - 2024' report provides comprehensive global coverage of available, marketed, and [...]

Published
2024

32. Global Antibody-Drug Conjugate Market Set for a ~USD 26 Billion Surge by 2030 | DelveInsight

Subjects
Daiichi Sankyo Company Ltd. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Business -- Research, Biopharmaceutics -- Reports -- Forecasts and trends, Viral antibodies -- Reports -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Antibodies -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

The antibody-drug conjugate market is on an exhilarating growth trajectory, fueled by innovative therapies and precision medicine. With advancements in targeted treatments and a surge in cancer cases, the demand [...]

Published
2024

33. Acute Ischemic Stroke Therapeutics Market to Grow by USD 1.74 Billion from 2024-2028, Driven by Rising Cardiovascular Disease Prevalence and AI-Driven Market Transformation - Technavio

Subjects
Athersys Inc. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Ischemia -- Forecasts and trends -- Reports, Anticoagulants (Medicine) -- Reports -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Tenecteplase -- Forecasts and trends -- Market size -- Reports, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following press release: Report with the AI impact on market trends - The Global Acute Ischemic Stroke Therapeutics Market size is estimated to grow [...]

Published
2024

34. 200+ Pharma Companies Vie for the Top Spot in the Expanding Antibody-Drug Conjugate Oncology Market | DelveInsight

Subjects
AstraZeneca PLC -- Forecasts and trends, Eisai Company Ltd. -- Forecasts and trends, Business -- Research, Biopharmaceutics -- Health aspects -- Reports -- Forecasts and trends, Viral antibodies -- Health aspects -- Reports -- Forecasts and trends, Antibodies -- Health aspects -- Reports -- Forecasts and trends, Industrial research -- United Kingdom -- Japan -- China, Pharmaceutical industry -- Forecasts and trends, Research and development, Market trend/market analysis, Business, News, opinion and commentary, Trodelvy (Medication) -- Reports -- Health aspects
Abstract

The ADC oncology market is experiencing rapid growth, attracting over 200 pharmaceutical companies vying for leadership in this innovative therapeutic space. As competition intensifies, advancements in technology and increased investment [...]

Published
2024

35. Global Cancer Therapy Market Size to grow at a CAGR of ~9% by 2030, Evaluates DelveInsight

Subjects
Merck & Company Inc. -- Forecasts and trends, Varian Medical Systems Inc. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Pfizer Inc. -- Forecasts and trends, Gilead Sciences Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Eli Lilly and Co. -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, Biological products industry -- Forecasts and trends, Medical equipment -- Health aspects -- Forecasts and trends, Business -- Research, Medical test kit industry -- Forecasts and trends, Antineoplastic agents -- Health aspects -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Medical equipment and supplies industry -- Forecasts and trends, Cancer -- Care and treatment -- Forecasts and trends -- Health aspects, Physiological apparatus -- Health aspects -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Antimitotic agents -- Health aspects -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-October 17, 2024-: Global Cancer Therapy Market Size to grow at a CAGR of ~9% by 2030, Evaluates DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:17102024 Cancer Therapy Companies working in the [...]

Published
2024

36. PARP Inhibitors Market to Register Immense Growth by 2034 Owing to Wider Opportunity in Multiple Indications with HRR (BRCA) Gene Mutations and Increasing Cost of Therapy of Leading PARP Inhibitors in the US | DelveInsight

Subjects
Merck & Company Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Gene mutations -- Forecasts and trends -- Reports -- Growth, Business -- Research, Genes -- Growth -- Reports -- Forecasts and trends, Metastasis -- Reports -- Forecasts and trends, Pancreatic cancer -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, News, opinion and commentary, Zejula (Medication) -- Reports, Talzenna (Medication) -- Reports, Lynparza (Medication) -- Reports
Abstract

The PARP inhibitors market is anticipated to experience substantial growth in the coming years. This growth is driven by label expansion of leading PARP inhibitors in various indications, a rising [...]

Published
2024

37. Post-Traumatic Stress Disorder (PTSD) Therapeutics Global Strategic Business Report 2024-2030 Featuring Apotex, AstraZeneca, Azevan, Bionomics, GSK, Novartis, Otsuka, Pfizer, and Tonix

Subjects
Apotex Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Medical research -- Forecasts and trends -- Reports, Medicine, Experimental -- Forecasts and trends -- Reports, Ecology -- Forecasts and trends -- Reports, Post-traumatic stress disorder -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'Post-Traumatic Stress Disorder (PTSD) Therapeutics - Global Strategic Business Report' report has been added to ResearchAndMarkets.com's offering. The global [...]

Published
2024

38. Triple-Negative Breast Cancer Market to Observe Stupendous Growth During the Study Period (2020-2034) | DelveInsight

Subjects
United States. Food and Drug Administration -- Reports, Pfizer Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Oncology, Experimental -- Forecasts and trends -- Growth -- Reports, Business -- Research, Cancer -- Research, Breast cancer -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international, Trodelvy (Medication) -- Reports
Abstract

M2 PRESSWIRE-October 8, 2024-: Triple-Negative Breast Cancer Market to Observe Stupendous Growth During the Study Period (2020-2034) | DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:08102024 The triple-negative breast cancer market dynamics are [...]

Published
2024

39. Biliary Tract Cancer Treatment Market Size in the 7MM was ~USD 1000 Million in 2023, estimated DelveInsight

Subjects
AstraZeneca PLC -- Forecasts and trends, Business -- Research, Antineoplastic agents -- Reports -- Forecasts and trends, Cancer -- Care and treatment, Epidemiology -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Antimitotic agents -- Reports -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-September 30, 2024-: Biliary Tract Cancer Treatment Market Size in the 7MM was ~USD 1000 Million in 2023, estimated DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:27092024 Biliary Tract Cancer Treatment Market [...]

Published
2024

40. Pancreatic Cancer Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Biotherapeutics, Keymed Biosciences Co. Ltd

Subjects
Merck & Company Inc. -- Forecasts and trends, Novartis AG -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, BCG vaccines -- Growth -- Forecasts and trends, BCG -- Growth -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Pancreatic cancer -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-September 27, 2024-: Pancreatic Cancer Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Biotherapeutics, Keymed Biosciences Co. Ltd [...]

Published
2024

41. The vaccine research market is projected to grow by USD 21.4 Billion from 2024-2028, with AI redefining the landscape and rising infectious diseases driving revenue - Technavio

Subjects
Astellas Pharma Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends, Medical research -- Forecasts and trends, Medicine, Experimental -- Forecasts and trends, Communicable diseases -- Forecasts and trends, BCG vaccines -- Forecasts and trends, BCG -- Forecasts and trends, Vaccines -- Forecasts and trends, Industrial research -- United Kingdom -- United States -- Japan, Pharmaceutical industry -- Forecasts and trends, Research and development, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: Report with market evolution powered by AI - The Global Vaccine Research Market size is estimated to grow by USD 21.4 [...]

Published
2024

42. Castrate-resistant Prostate Cancer Market to Show Remarkable Growth Trends from 2023 to 2032, Asserts DelveInsight | Pfizer, Astellas Pharma, Bristol-Myers Squibb, Laekna Therapeutics, Novartis

Subjects
Pfizer Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Novartis AG -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, BCG vaccines -- Growth -- Forecasts and trends -- Reports, Prostate cancer -- Forecasts and trends -- Reports, BCG -- Growth -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Company growth, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-September 24, 2024-: Castrate-resistant Prostate Cancer Market to Show Remarkable Growth Trends from 2023 to 2032, Asserts DelveInsight | Pfizer, Astellas Pharma, Bristol-Myers Squibb, Laekna Therapeutics, Novartis (C)1994-2024 M2 [...]

Published
2024

43. Asthma Treatment Market Size in the 7MM was ~USD 19,000 million in 2023, estimated DelveInsight

Subjects
AstraZeneca PLC -- Forecasts and trends, Teva Pharmaceutical Industries Ltd. -- Forecasts and trends, Business -- Research, Respiratory agents -- Reports -- Forecasts and trends, Epidemiology -- Forecasts and trends -- Reports, Monoclonal antibodies -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Asthma -- Drug therapy, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-September 18, 2024-: Asthma Treatment Market Size in the 7MM was ~USD 19,000 million in 2023, estimated DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:18092024 Asthma Treatment Market is projected to witness [...]

Published
2024

44. Metastatic Prostate Cancer Treatment Market Size is expected to grow with a significant CAGR during the study period (2020-2034)

Subjects
Merck & Company Inc. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Erleada (Medication) -- Reports, Nubeqa (Medication) -- Reports, Drug therapy, Reports, Forecasts and trends, Market trend/market analysis, Cancer treatment -- Reports -- Forecasts and trends, Business research -- Forecasts and trends -- Reports, Cabazitaxel -- Reports -- Forecasts and trends, Enzalutamide -- Reports -- Forecasts and trends, Cancer research -- Forecasts and trends -- Reports, Abiraterone -- Reports -- Forecasts and trends, Epidemiology -- Forecasts and trends -- Reports, Prostate cancer -- Drug therapy, Pharmaceutical industry -- Forecasts and trends, Cancer metastasis -- Drug therapy, Oncology, Experimental -- Forecasts and trends -- Reports, Business -- Research, Metastasis -- Drug therapy, Cancer -- Care and treatment -- Research
Abstract

M2 PRESSWIRE-September 16, 2024-: Metastatic Prostate Cancer Treatment Market Size is expected to grow with a significant CAGR during the study period (2020-2034) (C)1994-2024 M2 COMMUNICATIONS RDATE:16092024 Metastatic Prostate Cancer [...]

Published
2024

45. Questor: Ride the AI wave with this hidden gem from the FTSE 100; Share tip: the firm's strong, competitive position suggests further gains are ahead

Subjects
Unilever N.V. -- Forecasts and trends, RELX Group PLC -- Forecasts and trends, Hongkong and Shanghai Banking Corporation Ltd. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Food industry -- Forecasts and trends, Banking industry -- Forecasts and trends, Publishing industry -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Publishing industry, Market trend/market analysis, Food and beverage production/distribution software, Banking industry, General interest, News, opinion and commentary
Abstract

Byline: Robert Stephens Relx is probably the biggest UK-listed company you have never heard of. Its market capitalisation of £67bn makes it the sixth-largest FTSE 100 stock behind AstraZeneca, Shell, [...]

Published
2024

46. United States Dominates Global Pancreatic Cancer Market with 50% Share, Outpacing EU4, UK, and Japan, DelveInsight | AstraZeneca, Merck Sharp & Dohme LLC, Bayer, Roche, Celgene, Bristol Myers Squibb

Subjects
Bayer AG -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Celgene Corp. -- Forecasts and trends, Business -- Research, Adalimumab -- Forecasts and trends, Epidemiology -- Forecasts and trends, Pancreatic cancer -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international, Lynparza (Medication)
Abstract

M2 PRESSWIRE-September 6, 2024-: United States Dominates Global Pancreatic Cancer Market with 50% Share, Outpacing EU4, UK, and Japan, DelveInsight | AstraZeneca, Merck Sharp & Dohme LLC, Bayer, Roche, Celgene, [...]

Published
2024

47. Global Cancer Monoclonal Antibodies Market to Cross ~USD 157 Billion Mark by 2030 | DelveInsight

Subjects
Merck & Company Inc. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Novartis AG -- Forecasts and trends, AstraZeneca PLC -- Forecasts and trends, Business -- Research, Biotechnology industry -- Forecasts and trends, Cancer -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

The increasing demand for cancer monoclonal antibodies is mainly driven by the rising incidence of cancer, the growing prevalence of risk factors like smoking, radiation exposure, unhealthy lifestyles, and other [...]

Published
2024

48. Roche's PIASKY Approval for Paroxysmal Nocturnal Hemoglobinuria Treatment Will Give Tough Competition to AstraZeneca and Other Pharma Companies | DelveInsight

Subjects
AstraZeneca PLC -- Forecasts and trends, Business -- Research, Drug approval -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

Following achievements in Asia, Roche's PNH treatment drug PIASKY (crovalimab) received its first FDA approval. This approval has spiked the competition between Roche and current market leader AstraZeneca. Additionally, the [...]

Published
2024

49. AstraZeneca looks poised to beat the FTSE 100 during bull and bear markets alike. The pharmaceutical giant offers a potent mix of defensive characteristics and growth potential

Subjects
AstraZeneca PLC -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest
Abstract

Byline: ROBERT STEPHENS QUESTOR STOCK TIPS Read Questor's rules of investment before you follow our tips: telegraph.co.uk/go/questorrules AstraZeneca has generated a 78pc capital return since we first tipped it as [...]

Published
2024

50. Q1 2024 Innate Pharma SA Corporate Sales Call - Final

Subjects
AstraZeneca PLC -- Forecasts and trends, Sanofi S.A. -- Forecasts and trends, B cells -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Padcev (Medication)
Abstract

Presentation OPERATOR: Thank you for standing by, and welcome to the Innate Pharma first-quarter 2024 financial results and business update call. (Operator Instructions) Thank you. I'd now like to turn [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results